Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Cardiff Oncology Inc. buy krebskrebs

Start price
€1.08
16.10.23 / 50%
Target price
€1.60
16.10.24
Performance (%)
278.01%
Price
€4.08
30.04.24
Summary
This prediction is currently active. With a performance of 278.01% the BUY prediction by krebskrebs is a big success. This prediction currently runs until 16.10.24. The prediction end date can be changed by krebskrebs at any time. krebskrebs has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Cardiff Oncology Inc. 4.487% 4.487%
iShares Core DAX® -0.992% -3.231%
iShares Nasdaq 100 -0.225% -3.339%
iShares Nikkei 225® -0.736% -7.859%
iShares S&P 500 -0.509% -2.979%

Comments by krebskrebs for this prediction

In the thread Trovagene diskutieren
Prediction Buy
Perf. (%) 278.01%
Target price 1.600
Change
Ends at

Buy mit Kursziel 1,6